Login
Evidence Feed
About
Diagnostics
New
Top genes
FAQ
Contact us
^
Login
BIOMARKER:
FGF19 amplification + HRAS Q61R + TP53 672+2T>G
i
Other names:
TP53, Tumor Protein P53, Cellular Tumor Antigen P53, Phosphoprotein P53, Tumor Protein P53, Antigen NY-CO-13, Transformation-Related Protein 53, Mutant Tumor Protein 53, P53 Tumor Suppressor, Tumor Suppressor P53, Tumor Protein 53, BMFS5, TRP53, BCC7, LFS1, HRAS, HRAS1, Harvey rat sarcoma viral oncogene homolog, FGF19, Fibroblast growth factor 19
Associations
(6)
News
Trials
D | Sensitive
D | Resistant
Show legend
Include preclinical:
Drug categories
MDM2/MDMX
Other
Serine-Threonine Kinase Inhibitors
Chemokine
FGF
Tyrosine Kinase Inhibitors
Cyclin Dependent Kinase Inhibitors
CD Protein Inhibitors
Cancel
Prostate Cancer
APR-246
D
FGF19 amplification + HRAS Q61R + TP53 672+2T>G
|
Prostate Cancer
|
APR-246
MK-2206
D
FGF19 amplification + HRAS Q61R + TP53 672+2T>G
|
Prostate Cancer
|
MK-2206
tipifarnib
D
FGF19 amplification + HRAS Q61R + TP53 672+2T>G
|
Prostate Cancer
|
tipifarnib
erdafitinib
D
FGF19 amplification + HRAS Q61R + TP53 672+2T>G
|
Prostate Cancer
|
erdafitinib
INNO-406
D
FGF19 amplification + HRAS Q61R + TP53 672+2T>G
|
Prostate Cancer
|
INNO-406
abemaciclib
D
FGF19 amplification + HRAS Q61R + TP53 672+2T>G
|
Prostate Cancer
|
abemaciclib
^
^
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login